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Tumor necrosis factor related apoptosis-inducing ligand
(TRAIL) exerts a potent cytotoxic activity especially
against many tumor cell types such as transformed ker-
atinocytes. The speci¢c role of the di¡erent TRAIL re-
ceptors in this process, however, is unknown. In this
report we examine the role the TRAIL receptors play
in both the apoptotic and nonapoptotic responses
of HaCaT keratinocytes to leucine zipper TRAIL
(LZ-TRAIL). By employing receptor-speci¢c blocking
antibodies we demonstrate that TRAIL receptor 1 plays
the primary role in mediating caspase activation and
apoptosis in HaCaT cells. Furthermore, we show that
this receptor mainly mediates nuclear factor jB activa-
tion and expression of the pro-in£ammatory cytokine
interleukin-8 and that nuclear factor jB activation is
critically required for the induction of pro-in£amma-
tory cytokines in response to LZ-TRAIL. Taken
together, our data suggest that beside its potent pro-
apoptotic role, LZ-TRAIL leads to pro-in£ammatory
responses that are mainly mediated by TRAIL receptor
1 in HaCaT keratinocytes. Key words: apoptosis/IjB/
IL-8/IL-1Ra/NF-jB. J Invest Dermatol 121:149 ^155, 2003
T
he apoptosis-inducing members of the tumor necro-
sis factor (TNF) family, TNF, CD95/APO-1/Fas li-
gand (CD95L), and TNF-related apoptosis-inducing
ligand (TRAIL), have been studied intensively and
their role in activation-induced cell death, autoim-
mune disorders, immune privilege, and tumor evasion from the
immune system is now well established (reviewed by Walczak
and Krammer, 2000). The TRAIL system, consisting of the li-
gand and ¢ve di¡erent cellular receptors, has attracted attention
for its ability to preferentially kill tumor cells but not normal
cells (for a review see Daniel et al, 2001). The identi¢cation of
multiple TRAIL receptors (TRAIL-R) shows the complexity of
this death system and is indicative of its important physiologic
role. Whereas most studies have focused on the role of TRAIL
as a death ligand, early overexpression studies indicated that
TRAIL-R1, TRAIL-R2, and TRAIL-R4 can also mediate nu-
clear factor kB (NF-kB) activation (for a review seeWalczak and
Krammer, 2000;Wehrli et al, 2000). Since then, studies analyzing
theTRAIL-induced activation of nonapoptotic signaling pathways
under physiologic conditions have been sparse (Wajant et al, 2000;
2001; Harper et al, 2001).
Rel/NF-kB transcription factors are crucial regulators of many
physiologic and pathophysiologic processes such as in£ammation
and apoptosis.The mammalian Rel/NF-kB family consists of ¢ve
members that bind to regulatory DNA elements as homodimers
and/or heterodimers. The regulation of the nuclear translocation
of NF-kB is important for its function. The site-speci¢c phos-
phorylation by inhibitor of NF-kB (IkB) kinases (IKK) and the
subsequent proteasomal degradation of cytoplasmic inhibitory
proteins, the IkBs, are the key elements of this regulation (Karin
and Ben Neriah, 2000). In addition to its potent pro-in£amma-
tory function, activation of NF-kB and subsequent transcription
of numerous target genes represent important mechanisms for
the regulation of death-receptor-mediated apoptosis (Karin and
Lin, 2002).
In this report we extend our previous ¢ndings regarding the
role of TRAIL in keratinocytes by examining receptor-speci¢c
nonapoptotic and apoptotic signaling pathways.We demonstrate
that TRAIL induces activation of NF-kB and, through it, the
expression of genes involved in the in£ammatory responses
including interleukin-8 (IL-8) and the IL-1 receptor antagonist
(IL-1Ra). Retroviral infection of HaCaT cells with dominant-
negative mutants of IKK2 and IkBa con¢rms that activation
of NF-kB by TRAIL is critical for IL-8 expression but not
apoptosis. Finally, we demonstrate that it is mainly TRAIL-R1
that is responsible for leucine zipper TRAIL (LZ-TRAIL)
mediated activation of apoptotic and nonapoptotic signaling
pathways in HaCaT keratinocytes. Our data suggest an important
role for TRAIL not only in apoptosis induction but also in
chemotactic processes during pathophysiologic responses of the
skin.
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MATERIALS AND METHODS
Cell culture and reagents The spontaneously transformed keratinocyte
line HaCaT was kindly provided by Dr N. Fusenig (DKFZ Heidelberg)
and cultured as described previously (Boukamp et al, 1988). The protease
inhibitor z-Val-Ala-Asp-£uoromethyl ketone (zVAD-fmk) was obtained
from Bachem (Heidelberg, Germany). All other chemicals were of
reagent grade and obtained from Serva (Heidelberg, Germany). The
following antibodies were used: CPP32 (kindly provided by D.W.
Nicholson, Merck Frosst, Quebec, Canada), Flice (C-15; generously
provided by P.H. Krammer; now available from Alexis, Gruenberg,
Germany), caspase 10 (clone 4C1, MBL International, Watertown, MA),
RIP (Becton Dickinson, Heidelberg, Germany), IKK2 (Ab. 2684; New
England Biolabs, Boston, MA), IkBa (C-21; Santa Cruz Biotechnology,
Santa Cruz, CA). Horseradish peroxidase (HRP) tagged donkey
antirabbit antibodies and HRP-tagged goat antimouse IgG were from
Pharmingen (Hamburg, Germany), and HRP-conjugated goat antimouse
IgG1 and IgG2b were obtained from Southern Biotechnology
(Birmingham, AL). TRAIL-R1 (clone HS 101), TRAIL-R2 (clone HS
201), TRAIL-R3 (clone HS 301), TRAIL-R4 (clone HS402) monoclonal
antibodies (MoAb) for analysis of TRAIL-R1 to TRAIL-R4 surface
expression were generated as recently reported (Leverkus et al, 2003).
These MoAb are available from Alexis (Gruenberg, Germany).
Recombinant LZ-TRAIL was generated as published previously (Walczak
et al, 1997). Recombinant human TNF-a was obtained from Strathmann
Biotech, Hannover, Germany.
Apoptosis and cytotoxicity assays Crystal violet staining of surviving
attached cells was performed 16^24 h after addition of LZ-TRAIL in 24-
well plates (1105 cells) or in 96-well plates (2104 cells) as described
previously (Leverkus et al, 2000). In experiments using TRAIL-R1- and
TRAIL-R2-blocking MoAb, cells were preincubated with 10 mg per ml
of TRAIL-R MoAb for 1 h at 371C.
FACScan analysis Staining with TRAIL-R1- to TRAIL-R4-speci¢c
MoAb or isotyped control IgG was performed as described previously
(Leverkus et al, 2000) using MoAb against TRAIL-R1, TRAIL-R2,
TRAIL-R3, TRAIL-R4, or control mIgG1 at 10 mg per ml. Following
incubation with biotinylated secondary goat antimouse antibodies and
streptavidin-PE (Pharmingen, Hamburg, Germany), 104 cells were
analyzed by FACScan (Becton Dickinson, San Jose, CA).
Western blot analysis Total cellular proteins were collected as described
previously (Leverkus et al, 2000). 20^75 mg of protein were electrophoresed
on 8%^12% sodium dodecyl sulfate polyacrylamide gels and transferred
to nitrocellulose membranes, and immunodetection was performed as
described previously (Leverkus et al, 2003).
Electrophoretic mobility shift assay (EMSA) and supershift
EMSA EMSA was performed using nuclear extracts of HaCaT
keratinocytes as described previously (Marienfeld et al, 2001).
In vitro kinase assays HaCaT cells were lyzed in 200 ml KLBM bu¡er
containing 1 mm dithiothreitol, phenylmethylsulfonyl £uoride, and a
protease inhibitor cocktail (Roche, Basel, Switzerland). For each sample
300 mg of cellular protein lysate was subjected to immunoprecipitation
using an a-IKKg (NEMO) antibody (Santa Cruz, FL-419) or normal
rabbit serum as a control. The kinase assay and detection were performed
as previously described (Marienfeld et al, 1997) using 3 mg of GST-IkBaDC
(aa 1^54) as substrate.
RNase protection assays For RNase protection assays total RNAwas
extracted using Qiagen RNEasy Kit according to the manufacturer’s
recommendation. Five micrograms of total RNA were processed
according to PharMingen’s RiboQuant protocol (San Diego, CA) using
di¡erent multiprobe template sets.
Retroviral infection and generation of stable cell lines The pCFG5-
IEGZ retroviral vector containing inserts of transdominant IkBa (IkBa-
TD) mutant or kinase dead IKK2 (IKK2-KD) was used for infection of
HaCaT cells as described earlier (Denk et al, 2001) with the exception that
viral supernatants were generated in Dulbecco’s modi¢ed Eagle’s medium
containing 10% fetal bovine serum. Infection e⁄ciency of HaCaT cells
ranged between 50% and 80% as determined by green £uorescent
protein £uorescence 72 h after infection. Following two rounds of
selection with 500 mg per ml of zeocin (Invitrogen, Groningen, The
Netherlands) cells were 100% positive for green £uorescent protein (not
shown) and were subsequently used for biochemical characterization and
analysis of IL-8 secretion.
Determination of IL-8 secretion IL-8 secretion from keratinocyte
cultures was analyzed by ELISA (R & D Biosystems, Minneapolis, MN)
as described previously (Leverkus et al, 1998).
RESULTS
TRAIL induces NF-jB in HaCaT keratinocytes TRAIL
induces apoptosis in primary and transformed keratinocytes
(Leverkus et al, 2000). TRAIL, like TNF-a, however, might also
activate various other signaling pathways. In order to explore
whether TRAIL activates the important pro-in£ammatory
transcription factor NF-kB, we examined HaCaT keratinocytes
following treatment with this death ligand. In EMSA, we
detected an increase of nuclear NF-kB complexes within 15^30
min, further increasing through 1 h, and followed by a
subsequent decrease that correlated with a decreased cell
viability (Fig 1a and data not shown). Although the known
broad-spectrum caspase inhibitor zVAD-fmk completely
blocked TRAIL-induced apoptosis (Leverkus et al, 2000), NF-kB
activation was not blocked by zVAD-fmk (Fig 1a). In contrast, in
the presence of zVAD-fmk,TRAIL prolonged NF-kB activation
with DNA binding detectable for up to 4 h (Fig 1a and data not
shown) suggesting that a caspase-mediated signal may lead to
Figure1. TRAIL induces caspase-independent NF-jB activation
and transient phosphorylation of IjBa in HaCaT keratinocytes. (A)
HaCaT cells were treated for the indicated times with LZ-TRAIL (500 ng
per ml) and nuclear and cytoplasmic extracts were subsequently analyzed
for kB-speci¢c DNA binding by EMSA. Survival of cells was determined
in parallel experiments by crystal violet staining and is indicated as percen-
tage of control. TRAIL-induced NF-kB activation in the presence or ab-
sence of the broad-spectrum caspase inhibitor zVAD-fmk was analyzed
using nuclear protein extracts. The position of p65/p50 heterodimers or
p50 homodimers are indicated. (B) TRAIL-induced in vitro phosphoryla-
tion of IkBa. HaCaT cells were either left unstimulated (0) or stimulated
with TRAIL (500 ng per ml) in the absence or presence of 40 mM zVAD-
fmk for the indicated times.Whole cell protein extracts were immunopre-
cipitated with an a-IKKg antibody or a control serum (data not shown). As
a speci¢city control, extracts from keratinocytes stimulated with TRAIL
for 1 h were immunoprecipitated in the presence of the peptide recognized
by the antibody (peptide).The in vitro kinase reactions using GST-IkBa (1^54)
as a substrate were performed as described in Materials and Methods.
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downregulation of NF-kB activity.We subsequently analyzed the
intracellular signaling pathways of TRAIL-induced NF-kB
activation. As shown by an IKK-speci¢c immunocomplex
in vitro kinase assay, TRAIL treatment of HaCaT keratinocytes
led to the transient induction of IkBa phosphorylation within
30 min (Fig 1b). Consistent with the EMSA data, zVAD-fmk
did not block TRAIL-induced IkBa phosphorylation. The
retardation of IkBa phosphorylation (Fig 1b) compared to NF-
kB activation (Fig 1a) might be explained by the inability of
in vitro kinase assays to detect small changes in phosphorylation
levels. Taken together, these data demonstrate that TRAIL-
induced NF-kB activation is mediated via transient caspase-
independent IKK activation.
TRAIL induces the NF-jB target genes IL-8 and IL-1Ra
Beside their role as pro-apoptotic molecules, other death ligands
like TNF-a or CD95L are able to induce pro-in£ammatory
cytokines (Karin and Lin, 2002). Therefore, we investigated
whether TRAIL-induced NF-kB activation results in induction
of potential NF-kB target genes in HaCaT keratinocytes. The
TRAIL-mediated cytokine/chemokine gene induction was
analyzed by determining mRNA levels of IL-8, IL-1Ra, IL-1a,
IL-1b, or MCP-1 at di¡erent time points following TRAIL
stimulation using multiprobe ribonuclease protection assays. We
detected a 3- to 4-fold induction of IL-8 and a 2- to 3-fold
induction of IL-1Ra whereas the steady-state mRNA levels of
IL-1a, IL-1b, and MCP-1 remained unchanged (Fig 2a).
Induction of IL-8 and IL1-Ra was not signi¢cantly a¡ected
by addition of zVAD-fmk compared to control treated cells
(Fig 2a). Examination of culture supernatants of TRAIL-treated
HaCaT cells demonstrated a concentration-dependent induction
of IL-8 secretion (Fig 2b). Addition of zVAD-fmk resulted in
the detection of increased levels of IL-8 in culture supernatants,
particularly at higher concentrations of TRAIL. Taken together
we conclude that TRAIL is able to induce the important
neutrophil attractant IL-8, particularly under conditions when
TRAIL-mediated caspase activation is blocked.
TRAIL-induced IL-8 secretion critically requires activation
of NF-jB In other cell types IL-8 induction requires
cooperation of several distinct signaling pathways including NF-
kB and mitogen-activated protein kinase pathways (Holtmann
et al, 1999). In order to investigate if NF-kB is necessary for
TRAIL-induced IL-8 induction, we next studied whether ectopic
expression of dominant-negative mutants of IKK2 (IKK2-KD)
or IkBa (IkBa-TD) in£uenced IL-8 secretion in transformed
keratinocytes.We thus generated HaCaT cell lines overexpressing
IKK2-KD or IkBa-TD (Fig 3a). When compared to vector-
transfected control lines, overexpression of these molecules e⁄-
ciently inhibited TRAIL-induced degradation of IkBa (Fig 3a).
Whereas TRAIL-induced apoptosis was not signi¢cantly
a¡ected by speci¢c inhibition of NF-kB (Fig 3b), TRAIL- or
TNF-a-induced secretion of IL-8 was dramatically inhibited,
demonstrating that NF-kB activation is critically required
for TRAIL-induced IL-8 production in HaCaT keratinocytes
(Fig 3c).
LZ-TRAIL mediates pro-apoptotic and gene-inductive
signals mainly via TRAIL-R1 in HaCaT keratinocytes We
recently reported that under physiologic conditions keratinocytes
express TRAIL-R1 and TRAIL-R2 but not TRAIL-R3 or
TRAIL-R4 on the surface, despite high levels of mRNA
expression detected for TRAIL-R1, TRAIL-R2, and TRAIL-
R4 (Leverkus et al, 2000). Using a newly generated panel of
TRAIL-R-speci¢c MoAb, we con¢rmed our previous data for
TRAIL-R1 and TRAIL-R2, but could also detect TRAIL-R4
on the surface of HaCaT cells similar to our ¢ndings in primary
keratinocytes (Fig 4 and data not shown). Thus, we investigated
the relative contribution of physiologic levels of membrane-
bound TRAIL receptors using receptor-speci¢c MoAb to inhibit
TRAIL-R1- and TRAIL-R2-mediated signaling. The combi-
nation of MoAb directed against TRAIL-R1 and TRAIL-R2
fully blocked TRAIL-induced apoptosis, con¢rming that only
TRAIL-R1 and TRAIL-R2 mediate the apoptosis-inducing
signals (Fig 5a). Interestingly, 10 mg per ml of TRAIL-R1-
speci¢c MoAb alone led to 70%^90% inhibition of TRAIL-
induced apoptosis, whereas the TRAIL-R2-speci¢c MoAb only
marginally protected HaCaT keratinocytes against TRAIL-
induced apoptosis at the same concentration (Fig 5a). Similar
results were obtained in the presence of 100 mg per ml of either
MoAb (data not shown). As the combination of both antibodies
completely inhibited TRAIL-induced apoptosis (Fig 5a) and
fully blocks formation of the death-inducing signaling complex
(Sprick et al, 2002), we rule out ine¡ective inhibition of each
receptor by the individual TRAIL-R antibodies as the reason
for the detected di¡erence. To further analyze the receptor-
speci¢c activation of apoptotic and nonapoptotic signaling
pathways at the molecular level, we next examined the
activation of the initiator caspases 8 and 10 (Walczak and Sprick,
2001), the major e¡ector caspase 3 (Nicholson, 1999), as well as
NF-kB activation following TRAIL stimulation in the presence
of receptor-speci¢c MoAb. Cleavage of caspases 8, 10, and 3
was undetectable in cells treated with LZ-TRAIL in the pre-
sence of both TRAIL-R1- and TRAIL-R2-speci¢c MoAb
(Fig 5b). Caspase 10, caspase 8, and caspase 3 activation was
substantially reduced or undetectable, however, in the presence
of antagonistic TRAIL-R1-speci¢c antibodies, whereas TRAIL-
R2 antibody alone was ine¡ective in protecting against LZ-
TRAIL-induced caspase 8 or 10 activation (Fig 5b). Similarly
the combination of both MoAb directed against TRAIL-R1 and
TRAIL-R2 fully blocked TRAIL-induced NF-kB activation.
These data demonstrate that TRAIL death receptors but not
TRAIL-R4 mediate NF-kB activation at a physiologic
expression level in HaCaT cells (Fig 5c). Similar to the ¢ndings
for caspase activation, a strong reduction (70%^90%) of TRAIL-
induced NF-kB activation was seen upon TRAIL-R1 inhibition,
whereas TRAIL-R2 inhibition resulted in a marginal reduction
(10%^30%) of NF-kB activation (Fig 5c). Lastly, we examined
TRAIL-R-speci¢c IL-8 release. As TRAIL-R1 but not TRAIL-
R2 induced substantial apoptosis in HaCaT keratinocytes this set
of experiments was conducted in the presence of zVAD-fmk to
exclude the apoptosis-related reduction of total cell number
during the 24 h incubation period. In line with the ¢ndings in
Fig 5(a)(c), TRAIL-R1- but not TRAIL-R2-speci¢c MoAb
signi¢cantly inhibited TRAIL-induced IL-8 release (Fig 5d).
Consistent with the ¢nding that 10 mg per ml of TRAIL-R1
and TRAIL-R2 MoAb are unable to completely block apoptosis
induced by 1 mg per ml of TRAIL (data not shown), IL-8
secretion could not be fully inhibited by blocking MoAb at this
concentration of TRAIL (Fig 5d). Taken together, these results
suggest that TRAIL-R1 is predominantly mediating apoptosis
induction, NF-kB activation, and cytokine induction in HaCaT
keratinocytes in response to LZ-TRAIL.
DISCUSSION
TRAIL has been extensively studied for its role in the induction
of apoptosis (Walczak and Krammer, 2000). Emerging evidence,
however, suggests that, beside its pro-apoptotic properties,
TRAIL might also signal for nonapoptotic responses like
NF-kB activation (Wajant et al, 2000; Harper et al, 2001). In this
study, we found that TRAIL potently induces IKK activation and
NF-kB-speci¢c DNA binding in human HaCaT keratinocytes.
Such an NF-kB activation was not found in the keratinocyte
cell line KB (Kothny-Wilkes et al, 1998), whereas TRAIL-
induced NF-kB activation has been reported in Kym-1, Hela,
and astroglioma cells as well as primary keratinocytes (Wajant
et al, 2000; Harper et al, 2001; Choi et al, 2002; Leverkus et al,
2003). In several experimental systems NF-kB activation required
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Figure 2. TRAIL induces IL-8 and IL-1Ra but not IL-1 or MCP-1 in HaCaT keratinocytes. (A) Following preincubation with either diluent alone
or 40 mM zVAD-fmk for 1 h, HaCaTcells were treated with 500 ng per ml LZ-TRAIL for the indicated times. Multiprobe RNase protection assays (human
CK2 and CK5, RiboQuant) were performed using 5 mg of total RNA. Among other genes (data not shown), steady-state levels for IL-1b, IL-1a, IL-1Ra,
MCP-1, and IL-8 were determined by normalizing against the expression of the L32 housekeeping gene. Phosphoimager densitometry was performed and
densitometric units (normalized against L32 expression) are indicated for IL-1Ra and IL-8. (B) TRAIL-induced IL-8 secretion in HaCaT cells. Cells were
preincubated with either diluent alone (white bars) or 40 mM zVAD-fmk (¢lled bars) and subsequently treated with the indicated concentrations of LZ-
TRAIL or TNF-a for 24 h, and supernatants were assayed for IL-8 by ELISA.Viability of cells was determined by crystal violet assay.
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the presence of caspase inhibitors like zVAD-fmk (Wajant et al,
2000; Harper et al, 2001). In contrast, our detailed kinetic analysis
demonstrates that NF-kB activation and target gene induction
is achieved also in the absence of caspase inhibition at early
time points. Prolonged NF-kB activation is detectable upon cas-
pase inhibition, supporting the model that caspase-mediated sig-
nals inactivate necessary components of the NF-kB signaling
pathway such as RIP (Karin and Lin, 2002). Our ¢nding that
downregulation of NF-kB correlated with TRAIL-induced RIP
cleavage in keratinocytes (data not shown) is in line with these
¢ndings.
Potential NF-kB target genes are numerous and show distinct
cell type speci¢city (Pahl, 1999).We found that IL-8 and, to a les-
ser extent, IL-1Ra but not several other putative NF-kB target
genes were induced by TRAIL. Analysis of IL-8 secretion re-
vealed a concentration-dependent decrease of IL-8 secretion in
cultures treated with TRAIL alone correlating with the decrease
in cell viability, whereas a dose-dependent induction of IL-8 was
seen in the presence of zVAD-fmk. This suggests that the de-
creased IL-8 synthesis is due to increased apoptosis (and cell loss)
rather than to substantial di¡erences in NF-kB activity or IL-8
mRNA levels. This assumption is supported by a recent report
demonstrating IL-8 promoter activity in a larger cell population
upon caspase inhibition (Choi et al, 2002). IL-8 has been
shown to be speci¢cally regulated by di¡erent signaling path-
ways including mitogen-activated protein kinases and NF-kB
(Holtmann et al, 1999). We demonstrate by speci¢c inhibition
of NF-kB using dominant-negative forms of IKK2 or IkB
that TRAIL-induced expression of IL-8 is dependent upon
the NF-kB pathway. Nevertheless, it might be possible that
induction of IL-8 is mediated via cooperation of TRAIL-
induced NF-kB and mitogen-activated protein kinase pathways
in keratinocytes. Future studies will have to address this point in
more detail.
Chemokines like IL-8, MCP-1, and eotaxin contribute to the
regulation of epithelialization, tissue remodeling, and angiogen-
esis in human skin (Gillitzer and Goebeler, 2001). Our observa-
tion that TRAIL induces IL-8 in HaCaT keratinocytes suggests
a role for this TNF family member also in in£ammation and
recruitment of leukocytes to the skin.We speculate that TRAIL,
expressed on keratinocytes or on the surface of in¢ltrating
natural killer cells or activated T cells, might thus elicit a pro-in-
£ammatory and chemotactic response, particularly when cell
death pathways are tightly inhibited. IL-1Ra, the second
gene found upregulated by TRAIL in HaCaT, has potent anti-
in£ammatory properties exerted by competitive inhibition of
IL-1 binding to its receptors (Irikura et al, 2002). In contrast to
this endogenous inhibitor of IL-1 signaling, IL-1a and IL-1b are
not induced byTRAIL, suggesting a speci¢c downregulation of
IL-1 responses following TRAIL treatment. As IL-1 is able to
protect against TRAIL-induced apoptosis in KB cells (Kothny-
Wilkes et al, 1998), we speculate that TRAIL-induced IL-1Ra
might antagonize IL-1-induced antiapoptotic e¡ects such as
the activation of NF-kB. Taken together we suggest that TRAIL
may speci¢cally modulate chemotactic and in£ammatory
pathways important for the skin immune system. Further
in vivo studies are required to delineate the importance of these
TRAIL-induced signals during in£ammatory skin diseases and
carcinogenesis.
The role of the individual TRAIL receptors for apoptosis sig-
naling and gene induction has been mainly addressed by overex-
pression studies. In particular TRAIL-R4 has been suggested to
signal for NF-kB activation, although most studies have been
conducted by ectopic expression of this receptor (for a review
seeWalczak and Krammer, 2000).We detected bothTRAIL death
receptors and TRAIL-R4 on the surface of HaCaT keratinocytes
and primary keratinocytes in vitro (Fig 4 and data not shown).
Nevertheless, the full inhibition of caspase activation and NF-
kB activity by MoAb to TRAIL-R1 and TRAIL-R2 demon-
strates that NF-kB activation in HaCaT is only due to signals
mediated byTRAIL-R1 and/or TRAIL-R2. It remains to be de-
termined if and howTRAIL-R4 is regulated in vivo and which
stimuli may lead to upregulation of this TRAIL-R thereby even-
tually leading to TRAIL-R4-dependent NF-kB activation and
target gene expression.
Although both TRAIL-R1 and TRAIL-R2 are expressed in
HaCaT keratinocytes,TRAIL-R1was signi¢cantly more e⁄cient
for the induction of apoptosis, caspase activation, NF-kB stimula-
tion, and IL-8 induction following LZ-TRAIL stimulation. This
Figure 3. TRAIL-induced IL-8 induction but not apoptosis is criti-
cally dependent on NF-jB in HaCaT keratinocytes. (A) Overexpres-
sion of IKK2-KD or IkBa-TD inhibits IkBa degradation. Stable HaCaT
lines overexpressing IKK2-KD or IkBa-TD were stimulated with 250 ng
per ml TRAIL for 1 h and lysates were examined for IKK2, IkBa, and tu-
bulin expression by western blotting. (B) Stable HaCaT lines overexpres-
sing IKK2-KD or IkBa-TD were treated with the indicated
concentrations of LZ-TRAIL for 16 h, and analyzed for apoptosis induc-
tion by hypodiploidy analysis. Duplicate wells were analyzed. Shown are
the mean and SD of a total of three independent experiments. (C) Stable
HaCaT lines overexpressing IKK2-KD or IkBa-TD were treated either
with 250 or 1000 ng per ml of LZ-TRAIL or with TNF-a (1000 U per
ml) for 24 h in the presence or absence of zVAD-fmk (40 mM). Duplicate
wells were analyzed for IL-8 secretion by ELISA. Shown are the mean and
SD of a representative experiment.
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unexpected ¢nding might be due either to di¡erences in receptor
expression or, alternatively, to functional di¡erences of the
TRAIL death receptors in HaCaT keratinocytes. It is currently
unknown which type of TRAIL oligomerization is required for
e⁄cient TRAIL-R ligation in vivo, although it has been suggested
that TRAIL-R1 and TRAIL-R2 have distinct crosslinking
requirements with regard to gene induction and apoptosis
(Muhlenbeck et al, 2000; Wajant et al, 2001). Importantly, our
Figure 4. TRAIL receptor expression of HaCaT keratinocytes. HaCaT keratinocytes were analyzed for surface expression of TRAIL-R1TRAIL-
R4. Cells (2  105) were incubated with 10 mg per ml MoAb against TRAIL-R1,TRAIL-R2,TRAIL-R3, or TRAIL-R4 or control mIgG1, followed by
biotinylated secondary goat antimouse antibodies and streptavidin-PE. 104 cells were analyzed by FACScan.
Figure 5. TRAIL-R-speci¢c induction of apoptosis, caspase cleavage, and NF-jB activation. HaCaT keratinocytes were preincubated with 10 mg
per ml of the TRAIL-R-speci¢c antibodies or of isotype-matched control antibodies (IgG) for 1 h and subsequently stimulated with the indicated concen-
trations of LZ-TRAIL. (A) Viability was determined by crystal violet assay after 24 h. Shown are the mean and SD of duplicate wells of a representative
experiment. (B) Western blot analysis of caspase 8, caspase 10, and caspase 3 activation. After treatment of HaCaT keratinocytes with 500 ng per ml LZ-
TRAIL for 60 min, cytoplasmic proteins were prepared and analyzed by western blotting. (C) Nuclear extracts from the same experiment shown in (B)
were analyzed for NF-kB-speci¢c DNA binding by EMSA. (D) HaCaTcells were seeded in 96-well plates and preincubation with blockingTRAIL-R1- or
TRAIL-R2-speci¢c antibodies was performed after addition of 40 mM of zVAD-fmk for 1 h. Cells were stimulated with the indicated concentrations of
LZ-TRAIL for 24 h and supernatants were analyzed by an IL-8-speci¢c ELISA. Under these conditions, viability was always 100% as determined by crystal
violet assay (data not shown).
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study was solely performed with trimerized LZ-TRAIL that
might behave di¡erently from other recombinant forms of
TRAIL described thus far. Therefore our data do not exclude that
di¡erent TRAIL preparations might have di¡erent signaling
properties for TRAIL-R1 or TRAIL-R2. Future studies analyz-
ing the receptor-speci¢c death-inducing signaling complex com-
position in keratinocytes under physiologic conditions and using
di¡erent TRAIL preparations are required to answer this impor-
tant question. Interestingly, several TRAIL-resistant epithelial tu-
mor cell lines either lacked TRAIL-R1 expression or had
mutations in the TRAIL-R1 death domain and were resistant to
TRAIL-induced apoptosis, indicating that TRAIL-R1may be of
great importance in tumor progression of epithelial cancers (Kim
et al, 2000). Moreover, TRAIL and TRAIL-R may be regulated
by ultraviolet irradiation, thereby representing important sensors
of ultraviolet damage to the skin in order to maintain skin integ-
rity and preventing cell transformation during ultraviolet-induced
carcinogenesis (Bachmann et al, 2001). Taken together, our data
support a model that, at least in HaCaT keratinocytes, TRAIL-
R1 predominantly mediates TRAIL-induced signaling processes.
In conclusion, we show that, similar toTNF-a,TRAIL is able
to modulate di¡erent pro-in£ammatory and chemotactic cellular
responses via activation of NF-kB. LZ-TRAIL-mediated NF-kB
and caspase activation is mainly mediated via TRAIL-R1 in hu-
man HaCaT keratinocytes. Furthermore, we show that TRAIL
potently induces the NF-kB target gene IL-8 and IL-1Ra.
TRAIL-induced IL-8 upregulation might have important impli-
cations for the pathogenesis of various skin diseases that involve
in¢ltration of the skin with neutrophilic granulocytes such as
psoriasis and other neutrophilic dermatoses (Giustizieri et al,
2001). These gene-inductive properties might be balanced against
the sensitivity to TRAIL-induced apoptosis and could be
in£uenced by physiologic inhibitors of caspase activity. Under
conditions of e⁄cient intracellular inhibition of caspases, theTRAIL-
induced modulation of pro-in£ammatory signals might be of
great physiologic and pathophysiologic relevance in the skin.
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